These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 75686)

  • 41. [Experimental herpetic infection in rabbits combined with immunodepression (author's transl)].
    Bogossian M; Huraux JM; Nicolas JC; Begué P; Bricout F
    Ann Microbiol (Paris); 1975 Sep; 126(2):221-30. PubMed ID: 1217787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
    Birkeland SA
    Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Available methods to modify primary graft rejection (author's transl)].
    Prange CH; Kliems G
    Wien Klin Wochenschr; 1977 Jul; 89(14):465-74. PubMed ID: 302531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE; Ackman CF; Horowitz I
    Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing platelet survival during antilymphocyte globulin treatment.
    Gratama JW; Brand A; Jansen J; Zwaan FE; Valentijn RM; Eernisse JG
    Br J Haematol; 1984 May; 57(1):5-15. PubMed ID: 6722037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antilymphocyte globulin and adrenal steroids in the treatment of multiple sclerosis: short report based on seven cases.
    Cendrowski W
    Boll Ist Sieroter Milan; 1979 Sep; 58(4):339-43. PubMed ID: 553516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on the immunogenicity of antigen-antibody precipitates. II. The suppressive effect of anti-carrier and anti-hapten antibodies on the immunogenicity of dinitrophenylated human gamma G globulin.
    Henney CS; Ishizaka K
    J Immunol; 1970 Jun; 104(6):1540-9. PubMed ID: 4195052
    [No Abstract]   [Full Text] [Related]  

  • 49. Antilymphocyte globulin in cadaveric renal transplantation--a controlled trial.
    Jakobsen A; Sødal G; Flatmark A; Thorsby E
    Scand J Urol Nephrol Suppl; 1977; (42):94-6. PubMed ID: 356233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 51. Experimental infection with Ancylostoma caninum larvae in mice. VI. Serum protein pattern use due to repeated exposures to infection.
    Bhopale MK; Johri GN
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(1):95-103. PubMed ID: 93128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental hyperglobulinemia; the effect of injected ribonucleotide on serum globulin levels in rabbits undergoing immunization.
    RICHTER GW
    J Exp Med; 1952 May; 95(5):331-46. PubMed ID: 12981218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EFFECT OF AN ALPHA-2 GLOBULIN FRACTION ON ANTIBODY FORMATION IN RABBITS AND MICE.
    SPIEGELBERG HL; WEIGLE WO
    Proc Soc Exp Biol Med; 1964 Nov; 117():413-6. PubMed ID: 14233457
    [No Abstract]   [Full Text] [Related]  

  • 54. [EFFECT OF BODY TEMPERATURE CHANGE IN EXPERIMENTAL CONDITIONS ON THE BLOOD PROTEIN SPECTRUM AND SYNTHESIS OF ANTIBODIES].
    KEVORKOV NN
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Mar; 41():126-9. PubMed ID: 14187940
    [No Abstract]   [Full Text] [Related]  

  • 55. [The risk of ALG therapy possible side effects: prevention and treatment (author's transl)].
    Ring J; Seifert J; Lob G; Land W; Coulin K; Brendel W
    Klin Wochenschr; 1973 May; 51(10):487-93. PubMed ID: 4795666
    [No Abstract]   [Full Text] [Related]  

  • 56. Discussion paper: in vivo and in vitro studies of suppression of the antibody response by anti-macrophage globulin.
    Stevenson JR; Stavitsky AB
    Ann N Y Acad Sci; 1973 May; 207():172-7. PubMed ID: 4542615
    [No Abstract]   [Full Text] [Related]  

  • 57. [STUDIES ON AN ANTIBODY FORMATION PROMOTING FUNCTION OF LYMPHOCYTES. I. PRECIPITIN FORMATION PROMOTING FUNCTION OF LYMPHOCYTES AND OTHER MONONUCLEAR CELLS].
    SAWAI Y
    Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():568-80. PubMed ID: 14095687
    [No Abstract]   [Full Text] [Related]  

  • 58. A nonimmunoglobulin precipitin to tissue extracts in pathological human sera.
    Kim DS; Milgrom F
    Proc Soc Exp Biol Med; 1988 Nov; 189(2):196-200. PubMed ID: 2461571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The role of urinary proteins of alpha1 globulin fraction in the formation of urinary calculi with special reference to the aggregating effect of serum alpha1 globulin on CaCO3 suspension (author's transl)].
    Kisaki N
    Nihon Hinyokika Gakkai Zasshi; 1977 Jun; 68(6):590-98. PubMed ID: 72183
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter: Clarification of certain characteristics of chicken antilymphocyte globulin.
    Morris RE; Dong E
    Transplantation; 1976 Jun; 21(6):511-3. PubMed ID: 1084607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.